- ￥3260
- ProteoGenix
- France
- PTX20632
- 2025年07月14日
- ELISA, WB
- Human
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 免疫原：
Human
- 亚型：
IgG1, kappa
- 形态：
Liquid
- 保存条件：
0.01M PBS, pH 7.4.
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Human
- 保质期：
1 year
- 抗原来源：
Human
- 级别：
科研级别
- 库存：
999
- 供应商：
ProteoGenix
- 宿主：
Human
- 应用范围：
ELISA, WB
- 浓度：
1 mg/ml
- 抗体英文名：
Anti-Human TNFSF15/TL1A Antibody (ABS0175)
- 抗体名：
Anti-Human TNFSF15/TL1A Antibody (ABS0175)
- 规格：
100ug
| Product name | Anti-Human TNFSF15/TL1A Antibody (ABS0175) |
|---|---|
| Brand | ProteoGenix |
| Reference | PTX20632 |
| Host species | Human |
| Isotype | IgG1, kappa |
| Species reactivity | Human |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Concentration | 1 mg/ml |
| Purity | >95% as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Applications | ELISA, WB |
| Target | TNFSF15, Vascular endothelial cell growth inhibitor, VEGI, TL1, TNF ligand-related molecule 1, Tumor necrosis factor ligand superfamily member 15 |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | Please contact with the lab for this information. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Alternative Names | \ |
| Note | For research use only. |
ProteoGenix, founded in 2003 and headquartered in France, is a leading biotechnology company specializing in the development and production of high-quality research reagents. With a strong commitment to innovation, ProteoGenix provides a comprehensive range of antibodies, proteins, and molecular biology tools to support life science research worldwide. Our mission is to accelerate scientific discoveries by delivering reliable and cutting-edge solutions tailored to the needs of researchers.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
